[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
[HTML][HTML] High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001–2012)
M Malekinejad, S Navadeh, A Lotfizadeh… - International Journal of …, 2015 - Elsevier
Objective Drug users, particularly drug injectors, are at elevated risk of blood-borne
diseases. This study systematically reviewed the prevalence of hepatitis C virus (HCV) mono …
diseases. This study systematically reviewed the prevalence of hepatitis C virus (HCV) mono …
[BOOK][B] Drug-induced liver disease
N Kaplowitz, LD DeLeve - 2007 - taylorfrancis.com
Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable
reference for gastroenterologists, hepatologists, family physicians, internists, pathologists …
reference for gastroenterologists, hepatologists, family physicians, internists, pathologists …
High plasma efavirenz level and CYP2B6* 6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naive HIV patients from Ethiopia: a …
G Yimer, W Amogne, A Habtewold… - The …, 2012 - nature.com
The objective of this study was to assess the incidence, timing and identify
pharmacogenetic, efavirenz (EFV) pharmacokinetic and biochemical predictors of EFV …
pharmacogenetic, efavirenz (EFV) pharmacokinetic and biochemical predictors of EFV …
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
Background Drug-related toxicity has been one of the main causes of antiretroviral treatment
discontinuation. However, its determinants are not fully understood. Aim of this study was to …
discontinuation. However, its determinants are not fully understood. Aim of this study was to …
HIV-related liver disease: ARV drugs, coinfection, and other risk factors
M Puoti, P Nasta, F Gatti, A Matti… - Journal of the …, 2009 - journals.sagepub.com
Highly-active antiretroviral therapy (HAART) has proven remarkably effective for prolonging
the life of patients with human immunodeficiency virus (HIV). However, while most HAART …
the life of patients with human immunodeficiency virus (HIV). However, while most HAART …
Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without …
M Mendeni, E Foca, D Gotti, N Ladisa… - Clinical Infectious …, 2011 - academic.oup.com
Background. There is lack of data on the incidence of liver fibrosis (LF) progression in
patients with human immunodeficiency virus (HIV) monoinfection and risk factors for LF …
patients with human immunodeficiency virus (HIV) monoinfection and risk factors for LF …
Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study …
Objective HAART had significantly improved the quality of life of HIV patients. However, it
results different adverse effects such as: hepatotoxicity, nephrotoxicity, lipodystrophy …
results different adverse effects such as: hepatotoxicity, nephrotoxicity, lipodystrophy …
Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment …
SP Telatela, MI Matee, EK Munubhi - BMC public health, 2007 - Springer
Background With increased availability of antibiotics and antifungal agents hepatitis B virus
(HBV) and hepatitis C virus (HCV) infections are becoming a cause for significant concern in …
(HBV) and hepatitis C virus (HCV) infections are becoming a cause for significant concern in …
Incidence of hepatotoxicity and factors associated during highly active antiretroviral therapy in people living with HIV in Ethiopia: a prospective cohort study
G Gebremicael, HH Tola… - HIV/AIDS-Research …, 2021 - Taylor & Francis
Introduction Hepatotoxicity is one of the risk factors associated with treatment non-
adherence, which is the main risk factor for drug resistance. Therefore, this study aimed to …
adherence, which is the main risk factor for drug resistance. Therefore, this study aimed to …